Paris - Delayed Quote EUR

Neovacs S.A. (ALNEV.PA)

0.0066
-0.0013
(-16.46%)
At close: May 14 at 5:35:28 PM GMT+2
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,601.2200
-3,601.2200
-1,913.1650
-4,448.5120
-9,907.4540
Investing Cash Flow
1,450.3470
1,450.3470
-11,078.7290
-31,556.1740
-18,808.1830
Financing Cash Flow
1,699.2350
1,699.2350
6,793.3210
9,986.0550
51,745.7010
End Cash Position
435.4490
435.4490
887.0870
7,085.6610
33,104.2900
Capital Expenditure
-79.7060
-79.7060
-204.6980
-157.5920
-351.8060
Issuance of Capital Stock
2,132.0270
2,132.0270
5,653.0410
9,814.4150
51,055.7010
Issuance of Debt
1,087.2080
1,087.2080
6,190.2800
9,000
46,850
Repayment of Debt
-1,520
-1,520
-5,050
-8,828.3600
-46,160
Free Cash Flow
-3,680.9260
-3,680.9260
-2,117.8630
-4,606.1040
-10,259.2600
12/31/2021 - 4/21/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers